SCIFIO: an extensible framework to support scientific image formats.

SCIFIO: an extensible framework to support scientific image formats.

BACKGROUNDNo gold standard exists in the world of scientific image acquisition; a proliferation of instruments each with its own proprietary data format has made out-of-the-box sharing of that data nearly impossible. In the field of light microscopy, the Bio-Formats library was designed to translate such proprietary data formats to a common, open-source schema, enabling sharing and reproduction of scientific results. While Bio-Formats has proved successful for microscopy images, the greater scientific community was lacking a domain-independent framework for format translation.

RESULTSSCIFIO (SCientific Image Format Input and Output) is presented as a freely available, open-source library unifying the mechanisms of reading and writing image data. The core of SCIFIO is its modular definition of formats, the design of which clearly outlines the components of image I/O to encourage extensibility, facilitated by the dynamic discovery of the SciJava plugin framework. SCIFIO is structured to support coexistence of multiple domain-specific open exchange formats, such as Bio-Formats’ OME-TIFF, within a unified environment.

CONCLUSIONSSCIFIO is a freely available software library developed to standardize the process of reading and writing scientific image formats.

 SCIFIO: an extensible framework to support scientific image formats.
SCIFIO: an extensible framework to support scientific image formats.

mGlu2 agonist

A3601-5.1 10 mM (in 1mL H2O)
EUR 506.4
Description: LY2979165 is a novel potent agent that is used as Anti-depressants. LY2979165 is under clinical study. A Safety Study of LY2979165 is performing in Healthy Subjects. LY2979165 is useful for Anti-depressants.

mGlu2 agonist

A3601-50 50 mg
EUR 2013.6
Description: LY2979165 is a novel potent agent that is used as Anti-depressants. LY2979165 is under clinical study. A Safety Study of LY2979165 is performing in Healthy Subjects. LY2979165 is useful for Anti-depressants.

STING agonist-1

B7835-10 10 mg
EUR 309.6

STING agonist-1

B7835-50 50 mg
EUR 1120.8

STING agonist-3

HY-103665 5mg
EUR 542.4

STING agonist-1

HY-19711 100mg
EUR 3531.6

STING agonist-4

HY-123943 5mg
EUR 639.6

STING agonist-1

B7835-100 100mg
EUR 2911

STING agonist-1

B7835-5 5mg
EUR 485

Wnt agonist 1

B6059-10 10 mg
EUR 164.4
Description: Wnt agonist 1 is a small-molecule agonist of Wnt signaling pathway. The Wnt signaling pathway is an important signal transduction pathway that involved in a variety of physiological and pathological processes by regulating genes involved in cellular adhesion, proliferation, and differentiation.

Wnt agonist 1

B6059-200 200 mg
EUR 901.2
Description: Wnt agonist 1 is a small-molecule agonist of Wnt signaling pathway. The Wnt signaling pathway is an important signal transduction pathway that involved in a variety of physiological and pathological processes by regulating genes involved in cellular adhesion, proliferation, and differentiation.

Wnt agonist 1

B6059-5.1 10 mM (in 1mL DMSO)
EUR 129.6
Description: Wnt agonist 1 is a small-molecule agonist of Wnt signaling pathway. The Wnt signaling pathway is an important signal transduction pathway that involved in a variety of physiological and pathological processes by regulating genes involved in cellular adhesion, proliferation, and differentiation.

Wnt agonist 1

B6059-50 50 mg
EUR 428.4
Description: Wnt agonist 1 is a small-molecule agonist of Wnt signaling pathway. The Wnt signaling pathway is an important signal transduction pathway that involved in a variety of physiological and pathological processes by regulating genes involved in cellular adhesion, proliferation, and differentiation.

TPO agonist 1

HY-100380 10mM/1mL
EUR 297.6

FPR Agonist 43

HY-19574 50mg
EUR 1106.4

Smo Agonist, SAG

1939-1 each
EUR 210

Smo Agonist, SAG

1939-5 each
EUR 652.8

PPAR agonist 1

HY-U00340 20mg
EUR 11317.2

TLR7 agonist 2

HY-103039 10mg
EUR 1531.2

GPR40 Agonist 2

HY-U00395 5mg
EUR 13828.8

GPR40 agonist 4

HY-103083 100mg
EUR 1093.2

S1P1 Agonist III

HY-12835 10mg
EUR 308.4

Pparδ agonist 2

HY-100120 1mg
EUR 1870.8

STING AGONIST G10

B2047-25 each
EUR 705.6

STING AGONIST G10

B2047-5 each
EUR 222

STING Agonist C11

B2398-1 each
EUR 222

STING Agonist C11

B2398-5 each
EUR 705.6

DREADD Agonist 21

B1924-1 each
EUR 157.2

DREADD Agonist 21

B1924-5 each
EUR 444

GPR120 Agonist 2

HY-111353 100mg
EUR 2952

DREADD agonist 21

HY-100234 10mg
EUR 308.4

TGR5 Receptor Agonist

B1185-10 10 mg
EUR 351.6
Description: TGR5 Receptor Agonist is a potent and selective agonist of TGR5 G-protein receptor with a pEC50 value of 6.8 in the U2-OS cell assay [1].

TGR5 Receptor Agonist

B1185-25 25 mg
EUR 686.4
Description: TGR5 Receptor Agonist is a potent and selective agonist of TGR5 G-protein receptor with a pEC50 value of 6.8 in the U2-OS cell assay [1].

TGR5 Receptor Agonist

B1185-5 5 mg
EUR 226.8
Description: TGR5 Receptor Agonist is a potent and selective agonist of TGR5 G-protein receptor with a pEC50 value of 6.8 in the U2-OS cell assay [1].

TGR5 Receptor Agonist

1722-5 each
EUR 405.6

TGR5 Receptor Agonist

HY-14229 100mg
EUR 1354.8

TGR5 Receptor Agonist

B1185-100 100mg
EUR 1650
Description: TGR5 G-protein receptor agonist

TGR5 Receptor Agonist

B1185-50 50mg
EUR 960
Description: TGR5 G-protein receptor agonist

MC-4R Agonist 1

HY-U00396 1mg
EUR 5251.2

Ca2+ channel agonist 1

HY-41076 50mg
EUR 2539.2

S1p receptor agonist 1

HY-101265 50mg
EUR 2539.2

Orexin 2 Receptor Agonist

B1124-5 each
EUR 248.4

Anti- CD20 Agonist Antibody

71209 100 µg
EUR 325
Description: Anti-CD20 is a recombinant monoclonal antibody which features the constant region of the human IgG1 isotype and the variable region of rituximab. It binds to human CD20 extracellular region a.a 142- 184, where it acts asan agonist of the CD20 protein. Itis expressed in a 293 freestyle cell expression system and purified using protein A chromatography. MW = 150 kDa.

Orexin 2 Receptor Agonist

HY-19320 5mg
EUR 258

Troglitazone (PPARgamma agonist)

SIH-260-10MG 10 mg
EUR 201.6
Description: The substance Troglitazone is a ppargamma agonist. It is synthetically produced and has a purity of >98%. The pure substance is white solid which is soluble to 100 mM in DMSO and to 10 mM in ethanol.

Troglitazone (PPARgamma agonist)

SIH-260-50MG 50 mg
EUR 601.2
Description: The substance Troglitazone is a ppargamma agonist. It is synthetically produced and has a purity of >98%. The pure substance is white solid which is soluble to 100 mM in DMSO and to 10 mM in ethanol.

Anti-CD3 Agonist Antibody

71274-1 50 µg
EUR 355
Description: Recombinant human antibody recognizing the CD3 binding region on immune cells.

Anti-CD3 Agonist Antibody

71274-2 100 µg
EUR 510
Description: Recombinant human antibody recognizing the CD3 binding region on immune cells.

Kainic acid (Kainate agonist)

SIH-364-10MG 10 mg
EUR 261.6
Description: The substance Kainic acid is a kainate agonist. It is synthetically produced and has a purity of >99%. The pure substance is white powder which is May be dissolved in water (10 mg/ml).

Kainic acid (Kainate agonist)

SIH-364-50MG 50 mg
EUR 878.4
Description: The substance Kainic acid is a kainate agonist. It is synthetically produced and has a purity of >99%. The pure substance is white powder which is May be dissolved in water (10 mg/ml).

Glucocorticoid receptor agonist

A3438-10 10 mg
EUR 1372.8
Description: Glucocorticoid receptor agonist is a potent Glucocorticoid receptor agonist.

Glucocorticoid receptor agonist

A3438-5 5 mg
EUR 752.4
Description: Glucocorticoid receptor agonist is a potent Glucocorticoid receptor agonist.

Glucocorticoid receptor agonist

A3438-5.1 10 mM (in 1mL DMSO)
EUR 822
Description: Glucocorticoid receptor agonist is a potent Glucocorticoid receptor agonist.

Glucocorticoid receptor agonist

HY-14234 10mg
EUR 1059.6

Anti-CD27 Agonist Antibody

100111-1 50 µg
EUR 335
Description: Anti-CD27 agonist antibody binds to CD27 on T cells and promotes T cell response. It represents new opportunities for cancer immunotherapy.

Anti-CD27 Agonist Antibody

100111-2 100 µg
EUR 460
Description: Anti-CD27 agonist antibody binds to CD27 on T cells and promotes T cell response. It represents new opportunities for cancer immunotherapy.

Anti-CD28 Agonist Antibody

100182-1 50 µg
EUR 335
Description: Recombinant monoclonal antibody recognizing human CD28. This antibody binds to CD28 on T cells and promotes T cell response. Not tested in other species. This antibody crosslinked with FcGR2B is useful for activation of CD27 costimulatory pathway in T cells.

Anti-CD28 Agonist Antibody

100182-2 100 µg
EUR 460
Description: Recombinant monoclonal antibody recognizing human CD28. This antibody binds to CD28 on T cells and promotes T cell response. Not tested in other species.

Anti-CD137 Agonist Antibody

79097-1 50 µg
EUR 335
Description: Anti-CD137 recombinant human antibody recognizing the CD137 ligand binding region. This antibody not been tested for cross-reactivity with other species.

Anti-CD137 Agonist Antibody

79097-2 100 µg
EUR 460
Description: Anti-CD137 recombinant human antibody recognizing the CD137 ligand binding region. This antibody not been tested for cross-reactivity with other species.

VU0467154 (M4 Receptor Agonist)

SIH-184-10MG 10 mg
EUR 352.8
Description: The substance VU0467154 is a m4 receptor agonist. It is synthetically produced and has a purity of >98%. The pure substance is tan solid which is soluble in DMSO.

GLP-1 receptor agonist 1

HY-112185 10mM/1mL
EUR 2467.2

GLP-1 receptor agonist 2

HY-112679 10mM/1mL
EUR 850.8

Smo agonist, SAG dihydrochloride

2801-1 each
EUR 301.2

Smo agonist, SAG dihydrochloride

2801-5 each
EUR 901.2

Bexarotene (Retinoid RXR agonist)

SIH-535-100MG 100 mg
EUR 238.8
Description: The substance Bexarotene is a retinoid rxr agonist. It is synthetically produced and has a purity of >98%. The pure substance is white powder which is soluble in DMSO (60 mg/ml) or ethanol (warm, 10 mg/ml).

Bexarotene (Retinoid RXR agonist)

SIH-535-10MG 10 mg
EUR 164.4
Description: The substance Bexarotene is a retinoid rxr agonist. It is synthetically produced and has a purity of >98%. The pure substance is white powder which is soluble in DMSO (60 mg/ml) or ethanol (warm, 10 mg/ml).

PAR-4 Agonist Peptide, amide

HY-P1309 10mg
EUR 790.8

WY-14643 (PPAR alpha agonist)

SIH-531-250MG 250 mg
EUR 514.8
Description: The substance WY-14643 is a ppar alpha agonist. It is synthetically produced and has a purity of 0.985. The pure substance is off white powder which is soluble in DMSO (40 mg/ml).

WY-14643 (PPAR alpha agonist)

SIH-531-50MG 50 mg
EUR 192
Description: The substance WY-14643 is a ppar alpha agonist. It is synthetically produced and has a purity of 0.985. The pure substance is off white powder which is soluble in DMSO (40 mg/ml).

EZSolution? TGR5 Receptor Agonist

2538-5 each
EUR 392.4

Thrombin Receptor Agonist Peptide

A8668-1 1 mg
EUR 240
Description: Agonist at the thrombin receptor; causes platelet aggregation (EC50 = 4 ?M) and secretion.

Thrombin Receptor Agonist Peptide

A8668-10 10 mg
EUR 1341.6
Description: Agonist at the thrombin receptor; causes platelet aggregation (EC50 = 4 ?M) and secretion.

Thrombin Receptor Agonist Peptide

A8668-5 5 mg
EUR 781.2
Description: Agonist at the thrombin receptor; causes platelet aggregation (EC50 = 4 ?M) and secretion.

Thrombin Receptor Agonist Peptide

A8668-5.1 10 mM (in 1mL DMSO)
EUR 2720.4
Description: Agonist at the thrombin receptor; causes platelet aggregation (EC50 = 4 ?M) and secretion.

diABZI STING agonist-1 (trihydrochloride)

HY-112921B 10mM/1mL
EUR 1149.6

FXR Agonist Assay Kit (TR-FRET)

78131 384 rxns.
EUR 715
Description: The FXR (Farnesoid X Receptor) Agonist Assay Kit (TR-FRET) is designed to measure binding of the FXR and SRC-1 (Steroid Receptor Coactivator 1) for screening FXR agonists using TR-FRET technology. With this homogeneous kit, the FXR agonist assay can be performed by adding all materials, including the detection reagents, to the wells and incubating the plate for 2-hours at room temperature followed by reading the TR-FRET signal._x000D_

β cell proliferation agonist WS3

HY-12462 10mM/1mL
EUR 195.6

TLR7/8 agonist 1 (dihydrochloride)

HY-103698A 25mg
EUR 1575.6

Retinoic acid (Retinoid RAR agonist)

SIH-258-250MG 250 mg
EUR 128.4
Description: The substance Retinoic acid is a retinoid rar agonist. It is synthetically produced and has a purity of >98%. The pure substance is yellow solid which is soluble to 50 mM in ethanol and 25 mM in DMSO.

Retinoic acid (Retinoid RAR agonist)

SIH-258-50MG 50 mg
EUR 105.6
Description: The substance Retinoic acid is a retinoid rar agonist. It is synthetically produced and has a purity of >98%. The pure substance is yellow solid which is soluble to 50 mM in ethanol and 25 mM in DMSO.

PAR-4 Agonist Peptide, amide (TFA)

HY-P1309A 10mg
EUR 790.8

BH3 Interacting Domain Death Agonist

PR27259 2 ug
EUR 229.2

Anti-CD28 Agonist Antibody (Humanized)

100186-1 50 µg
EUR 345
Description: Recombinant monoclonal antibody recognizing human CD28. This antibody binds to CD28 on T cells and promotes T cell response. Not tested in other species. This antibody crosslinked with FcGR2B is useful for activation of CD27 costimulatory pathway in T cells. This antibody has been humanized to reduce immunogenicity and improve the therapeutic half-life.

Anti-CD28 Agonist Antibody (Humanized)

100186-2 100 µg
EUR 475
Description: Recombinant monoclonal antibody recognizing human CD28. This antibody binds to CD28 on T cells and promotes T cell response. Not tested in other species. This antibody has been humanized to reduce immunogenicity and improve the therapeutic half-life.

BzATP (Prototypic P2X7 receptor agonist)

SIH-420-25MG 25 mg
EUR 561.6
Description: The substance BzATP is a prototypic p2x7 receptor agonist. It is synthetically produced and has a purity of >97.7%. The pure substance is off white solid which is soluble in water..

BzATP (Prototypic P2X7 receptor agonist)

SIH-420-5MG 5 mg
EUR 198
Description: The substance BzATP is a prototypic p2x7 receptor agonist. It is synthetically produced and has a purity of >97.7%. The pure substance is off white solid which is soluble in water..

Orphan GPCR SP9155 Agonist P518 (human)

H-5984.0500 0.5mg
EUR 588
Description: Sum Formula: C127H195N37O37; CAS# [600171-68-4] net

Orphan GPCR SP9155 Agonist P518 (human)

H-5984.1000 1.0mg
EUR 1023.6
Description: Sum Formula: C127H195N37O37; CAS# [600171-68-4] net

Orphan GPCR SP9155 Agonist P550 (mouse)

H-5986.0500 0.5mg
EUR 588
Description: Sum Formula: C126H195N37O37; CAS# [600171-70-8] net

Orphan GPCR SP9155 Agonist P550 (mouse)

H-5986.1000 1.0mg
EUR 1023.6
Description: Sum Formula: C126H195N37O37; CAS# [600171-70-8] net

Quisqualic Acid (Glutamate receptor agonist)

SIH-418-10MG 10 mg
EUR 306
Description: The substance Quisqualic Acid is a glutamate receptor agonist. It is isolated from quisqualis fructus and has a purity of 0.999. The pure substance is off white solid which is soluble to 100 mM in 1eq. NaOH; 10 mM in water.

Quisqualic Acid (Glutamate receptor agonist)

SIH-418-50MG 50 mg
EUR 991.2
Description: The substance Quisqualic Acid is a glutamate receptor agonist. It is isolated from quisqualis fructus and has a purity of 0.999. The pure substance is off white solid which is soluble to 100 mM in 1eq. NaOH; 10 mM in water.

Imidazoquinoline (TLR7 Agonist) Antigen Grade

VAdv-Ly0018-25mg 25 mg
EUR 4332
Description: Imidazoquinoline, a TLR7 agonist vaccine adjuvant.

Imidazoquinoline (TLR7 Agonist) Antigen Grade

VAdv-Ly0018-5mg 5 mg
EUR 1033.2
Description: Imidazoquinoline, a TLR7 agonist vaccine adjuvant.

IL-1 Receptor Agonist Recombinant Protein

40-242-002mg 0.02 mg
EUR 311.1
Description: Interleukin-1 receptor antagonist (IL-1RA) is a naturally occurring inflammatory inhibitor protein. It inhibits the activity of IL-1α and IL-1β by competitively blocking binding to their type I and type II receptors. IL-1Ra is produced by corneal epithelial cells, monocytes, neutrophils, macrophages, and fibroblasts. Therapeutically, IL-1Ra may help in the treatment of sepsis, cachexia, rheumatoid arthritis, chronic myelogenous leukemia, asthma, psoriasis, and inflammatory bowel disease. Recombinant human IL-1Ra is a 17.2 kDa protein consisting of 153 amino acid residues.

IL-1 Receptor Agonist Recombinant Protein

40-242-01mg 0.1 mg
EUR 437.1
Description: Interleukin-1 receptor antagonist (IL-1RA) is a naturally occurring inflammatory inhibitor protein. It inhibits the activity of IL-1α and IL-1β by competitively blocking binding to their type I and type II receptors. IL-1Ra is produced by corneal epithelial cells, monocytes, neutrophils, macrophages, and fibroblasts. Therapeutically, IL-1Ra may help in the treatment of sepsis, cachexia, rheumatoid arthritis, chronic myelogenous leukemia, asthma, psoriasis, and inflammatory bowel disease. Recombinant human IL-1Ra is a 17.2 kDa protein consisting of 153 amino acid residues.

BH3 Interacting Domain Death Agonist p15 Protein

20-abx262317
  • EUR 393.60
  • EUR 7108.80
  • EUR 276.00
  • 10 ug
  • 1 mg
  • 2 µg

Human BH3-interacting domain death agonist (BID)

1-CSB-EP002698HU
  • EUR 456.00
  • EUR 256.80
  • EUR 1570.80
  • EUR 672.00
  • EUR 1047.60
  • EUR 314.40
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Human BH3-interacting domain death agonist(BID) expressed in E.coli

BH3 Interacting Domain Death Agonist (BID) Antibody

20-abx137416
  • EUR 844.80
  • EUR 393.60
  • EUR 276.00
  • 100 ug
  • 20 ug
  • 5 ug

BH3 Interacting Domain Death Agonist (Bid) Antibody

20-abx103690
  • EUR 427.20
  • EUR 159.60
  • EUR 1228.80
  • EUR 610.80
  • EUR 360.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

BH3 Interacting Domain Death Agonist (Bid) Antibody

20-abx103691
  • EUR 477.60
  • EUR 159.60
  • EUR 1328.40
  • EUR 644.40
  • EUR 376.80
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

BH3 Interacting Domain Death Agonist (Bid) Antibody

20-abx103692
  • EUR 510.00
  • EUR 159.60
  • EUR 1412.40
  • EUR 693.60
  • EUR 393.60
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

BH3 Interacting Domain Death Agonist (Bid) Antibody

20-abx175576
  • EUR 1362.00
  • EUR 661.20
  • 1 mg
  • 200 ug

BH3 Interacting Domain Death Agonist (Bid) Antibody

20-abx171416
  • EUR 944.40
  • EUR 493.20
  • 1 mg
  • 200 ug

BH3 Interacting Domain Death Agonist (Bid) Antibody

20-abx171417
  • EUR 393.60
  • EUR 1011.60
  • EUR 526.80
  • EUR 184.80
  • EUR 309.60
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

BH3 Interacting Domain Death Agonist (BID) Antibody

abx027196-400ul 400 ul
EUR 627.6

BH3 Interacting Domain Death Agonist (BID) Antibody

abx027196-80l 80 µl
EUR 343.2

4-Quinolone-3-Carboxamide Furan CB2 Agonist

C3511-10 10 mg
EUR 528
Description: Ki: 8.5 nM4-Quinolone-3-Carboxamide Furan CB2 Agonist is a high-affinity ligand of CB2.The endocannabinoid system consists of endogenous cannabinoids (endocannabinoids), cannabinoid receptors (primarily CB1 and CB2), and the enzymes that synthesize and degrade endocannabinoids.

4-Quinolone-3-Carboxamide Furan CB2 Agonist

C3511-25 25 mg
EUR 1082.4
Description: Ki: 8.5 nM4-Quinolone-3-Carboxamide Furan CB2 Agonist is a high-affinity ligand of CB2.The endocannabinoid system consists of endogenous cannabinoids (endocannabinoids), cannabinoid receptors (primarily CB1 and CB2), and the enzymes that synthesize and degrade endocannabinoids.

4-Quinolone-3-Carboxamide Furan CB2 Agonist

C3511-5 5 mg
EUR 324
Description: Ki: 8.5 nM4-Quinolone-3-Carboxamide Furan CB2 Agonist is a high-affinity ligand of CB2.The endocannabinoid system consists of endogenous cannabinoids (endocannabinoids), cannabinoid receptors (primarily CB1 and CB2), and the enzymes that synthesize and degrade endocannabinoids.

BH3-Interacting Domain Death Agonist (BID) Protein

20-abx262316
  • EUR 393.60
  • EUR 7108.80
  • EUR 276.00
  • 10 ug
  • 1 mg
  • 2 µg

BH3-Interacting Domain Death Agonist (BID) Protein

20-abx262325
  • EUR 393.60
  • EUR 7108.80
  • EUR 276.00
  • 10 ug
  • 1 mg
  • 2 µg

BH3-Interacting Domain Death Agonist (BID) Protein

20-abx262975
  • EUR 393.60
  • EUR 7676.40
  • EUR 276.00
  • 10 ug
  • 1 mg
  • 2 µg

Imiquimod (TLR7 agonist/Imidazoquinoline), antigen grade

AV-8015-25 25 mg
EUR 1074

Imiquimod (TLR7 agonist/Imidazoquinoline), antigen grade

AV-8015-5 5 mg
EUR 343.2

BH3-Interacting Domain Death Agonist (BID) Antibody

20-abx134969
  • EUR 427.20
  • EUR 644.40
  • EUR 260.40
  • 100 ul
  • 200 ul
  • 30 ul

BH3-Interacting Domain Death Agonist (BID) Antibody

abx230892-100ug 100 ug
EUR 577.2

BH3-Interacting Domain Death Agonist (BID) Antibody

abx230893-100ug 100 ug
EUR 577.2

BH3-Interacting Domain Death Agonist (BID) Antibody

20-abx109577
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

BH3-Interacting Domain Death Agonist (BID) Antibody

20-abx121852
  • EUR 360.00
  • EUR 526.80
  • EUR 226.80
  • 100 ul
  • 200 ul
  • 30 ul

BH3-Interacting Domain Death Agonist (BID) Antibody

20-abx325731
  • EUR 376.80
  • EUR 292.80
  • 100 ug
  • 50 ug

BH3-Interacting Domain Death Agonist (BID) Antibody

abx411825-01mg 0.1 mg
EUR 844.8

BH3-Interacting Domain Death Agonist (BID) Antibody

20-abx111223
  • EUR 878.40
  • EUR 477.60
  • 150 ul
  • 50 ul

BH3-Interacting Domain Death Agonist (BID) Antibody

abx027197-400ul 400 ul
EUR 627.6

BH3-Interacting Domain Death Agonist (BID) Antibody

abx027197-80l 80 µl
EUR 343.2

BH3-Interacting Domain Death Agonist (BID) Antibody

20-abx126843
  • EUR 493.20
  • EUR 710.40
  • 100 ul
  • 200 ul

BH3-Interacting Domain Death Agonist (BID) Antibody

20-abx323329
  • EUR 376.80
  • EUR 292.80
  • 100 ug
  • 50 ug

BH3-Interacting Domain Death Agonist (BID) Antibody

20-abx339965
  • EUR 493.20
  • EUR 360.00
  • 100 ul
  • 50 ul

BH3-Interacting Domain Death Agonist (BID) Antibody

20-abx339966
  • EUR 493.20
  • EUR 360.00
  • 100 ul
  • 50 ul

BH3-Interacting Domain Death Agonist (BID) Antibody

abx432407-200ul 200 ul
EUR 460.8

BH3-Interacting Domain Death Agonist (BID) Antibody

20-abx000598
  • EUR 493.20
  • EUR 710.40
  • EUR 218.40
  • EUR 376.80
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul

BH3-Interacting Domain Death Agonist (BID) Antibody

abx011976-100ul 100 ul
EUR 493.2

Bid Antibody / BH3-Interacting Domain Death Agonist

F54478-0.05ML 0.05 ml
EUR 140.25
Description: The major proteolytic product p15 BID allows the release of cytochrome c (By similarity). Isoform 1, isoform 2 and isoform 4 induce ICE-like proteases and apoptosis. Isoform 3 does not induce apoptosis. Counters the protective effect of Bcl-2.

Bid Antibody / BH3-Interacting Domain Death Agonist

F54478-0.2ML 0.2 ml
EUR 330.65
Description: The major proteolytic product p15 BID allows the release of cytochrome c (By similarity). Isoform 1, isoform 2 and isoform 4 induce ICE-like proteases and apoptosis. Isoform 3 does not induce apoptosis. Counters the protective effect of Bcl-2.

ODN 2216-Type A human TLR9 Agonist.-antigen grade

ODN2216-1 1 mg
EUR 781.2

ODN 2216-Type A human TLR9 Agonist.-antigen grade

ODN2216-5 5 mg
EUR 2389.2

BCL2 Associated Agonist Of Cell Death (BAD) Antibody

abx332054-100ul 100 ul
EUR 510

BCL2 Associated Agonist Of Cell Death (BAD) Antibody

abx332057-100ul 100 ul
EUR 510

BCL2 Associated Agonist Of Cell Death (BAD) Antibody

abx332059-100ul 100 ul
EUR 510

BCL2 Associated Agonist Of Cell Death (BAD) Antibody

20-abx326401
  • EUR 376.80
  • EUR 292.80
  • 100 ug
  • 50 ug

Rat BH3 Interacting Domain Death Agonist ELISA kit

E02B0306-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Rat BH3 Interacting Domain Death Agonist in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rat BH3 Interacting Domain Death Agonist ELISA kit

E02B0306-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Rat BH3 Interacting Domain Death Agonist in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rat BH3 Interacting Domain Death Agonist ELISA kit

E02B0306-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Rat BH3 Interacting Domain Death Agonist in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

BCL2 Associated Agonist of Cell Death (BAD) Antibody

20-abx111204
  • EUR 878.40
  • EUR 477.60
  • 150 ul
  • 50 ul

BCL2 Associated Agonist Of Cell Death (BAD) Antibody

20-abx328193
  • EUR 376.80
  • EUR 292.80
  • 100 ug
  • 50 ug

BCL2 Associated Agonist Of Cell Death (BAD) Antibody

20-abx328450
  • EUR 376.80
  • EUR 292.80
  • 100 ug
  • 50 ug

BCL2 Associated Agonist Of Cell Death (BAD) Antibody

20-abx329564
  • EUR 376.80
  • EUR 292.80
  • 100 ug
  • 50 ug

BCL2 Associated Agonist Of Cell Death (BAD) Antibody

20-abx329911
  • EUR 376.80
  • EUR 292.80
  • 100 ug
  • 50 ug

BCL2 Associated Agonist Of Cell Death (BAD) Antibody

20-abx339824
  • EUR 493.20
  • EUR 360.00
  • 100 ul
  • 50 ul

Dog BH3 Interacting Domain Death Agonist ELISA kit

E08B0306-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Canine BH3 Interacting Domain Death Agonist in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Dog BH3 Interacting Domain Death Agonist ELISA kit

E08B0306-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Canine BH3 Interacting Domain Death Agonist in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Dog BH3 Interacting Domain Death Agonist ELISA kit

E08B0306-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Canine BH3 Interacting Domain Death Agonist in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Pig BH3 Interacting Domain Death Agonist ELISA kit

E07B0306-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Porcine BH3 Interacting Domain Death Agonist in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Pig BH3 Interacting Domain Death Agonist ELISA kit

E07B0306-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Porcine BH3 Interacting Domain Death Agonist in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Leave a Comment

Your email address will not be published.

Scroll to Top